Michaeli, D., Michaeli, C. T., Albers, S., & Michaeli, J. (2024). Patient enrollment per month (accrual) in clinical trials leading to the FDA approval of new cancer drugs. Targeted oncology, 19(5), . https://doi.org/10.1007/s11523-024-01081-w
Chicago Style (17th ed.) CitationMichaeli, Daniel, Christoph T. Michaeli, Sebastian Albers, and Julia Michaeli. "Patient Enrollment Per Month (accrual) in Clinical Trials Leading to the FDA Approval of New Cancer Drugs." Targeted Oncology 19, no. 5 (2024). https://doi.org/10.1007/s11523-024-01081-w.
MLA (9th ed.) CitationMichaeli, Daniel, et al. "Patient Enrollment Per Month (accrual) in Clinical Trials Leading to the FDA Approval of New Cancer Drugs." Targeted Oncology, vol. 19, no. 5, 2024, https://doi.org/10.1007/s11523-024-01081-w.